BMS 795311 |
Katalog-Nr.GC50257 |
BMS 795311 ist ein potenter und oral bioverfügbarer Inhibitor des Cholesterylester-Transferproteins (CETP) mit IC50-Werten von 4 nM in einem enzymbasierten Szintillations-Proximity-Assay (SPA) bzw. 0,22 μM in einem Human-Vollplasma-Assay (hWPA).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 939390-99-5
Sample solution is provided at 25 µL, 10mM.
Potent cholesteryl ester transfer protein (CETP) inhibitor (IC50 = 4 nM in an enzyme-based scintillation proximity assay). Inhibits cholesteryl ester transfer and increases HDL-C levels in vivo. Orally bioavailable.
Qiao et al (2015) Triphenylethanamine derivatives as cholesteryl ester transfer protein inhibitors: discovery of N-[(1R)-1-(3-cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamid J.Med.Chem. 58 9010 PMID:26524347
Average Rating: 5
(Based on Reviews and 18 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *